soul trial oral semaglutide cardiovascular outcomes nejm 2025 results A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link Oral Semaglutide and Cardiovascular Outcomes

Since stopping the medication in September 2022, she has regained 40 pounds

Search by status and location: On ClinicalTrials.gov, filter by Status "Recruiting" and your ZIP code to surface only open trials near you

While Wegovy changed how we treat obesity, oral sema is about to change how we sell drugs

You might know alopecia areata (AA) from its patchy presentation, whereby slick-bald patches begin to form in a non-uniform fashion

Do not push through severe weakness

The study introduces a BMI adjustment methodology for calf circumference measurements, which effectively mitigates the confounding influences of adiposity, enhancing the accuracy of this measurement for estimating skeletal muscle mass